Business Context and Reporting Period
Company: SeaStar Medical Holding Corporation (Nasdaq: ICU)
Filing Type: Form 8-K (Current Report)
Report Date: August 12, 2026
Reporting Period: This filing announces the financial condition and results of operations for the three and six months ended June 30, 2026. The company is designated as an emerging growth company.
Key Financial Metrics
The provided text serves as a cover report referencing a press release (Exhibit 99.1) for detailed data. The filing text itself does not contain specific numerical values for:
- Revenue
- Profit or Loss
- Cash Flow
- Operating Margins
- Debt Levels
- Liquidity Position
Note: Specific financial figures are not present in the source text provided.
Material Changes
The filing text does not provide specific details regarding material changes in financial performance or position compared to prior periods. It only confirms the issuance of a press release containing this information.
Guidance, Outlook, and Risks
Management Commentary: The company issued a press release on August 12, 2026, detailing its results. The text explicitly states that the information in this 8-K, including the press release, is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section.
Risks and Contingencies: No specific risks, contingencies, or unusual items are detailed in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 12, 2026) for actual revenue, profit, and cash flow figures.
- Verify the specific operational metrics for the three and six months ended June 30, 2026, as they are not included in the 8-K body text.
- Confirm the status of the company's emerging growth company election and any related accounting standard transitions.
- Check for any subsequent filings that may incorporate the furnished information by reference.